Connect with us

Government

Global Stocks Slide After Fed Minutes Disappoint

Global Stocks Slide After Fed Minutes Disappoint

Published

on

Global Stocks Slide After Fed Minutes Disappoint Tyler Durden Thu, 08/20/2020 - 08:03

US equity futures, Asian and European markets fell on Thursday after the U.S. Federal Reserve’s latest meeting minutes did not guide to more easing or hint at yield curve control while highlighting doubts about the recovery of the world’s largest economy which knocked the S&P500 from its record highs, although sentiment got a modest boost overnight after China announced it had agreed with the US to resume trade talks "in the coming days" to evaluate the progress of their Phase 1 trade deal.

Among early movers, Nvidia Corp slipped 1.1% in premarket trade after results from the data center business of the rising semiconductor industry star disappointed some investors. Intel Corp rose 4% after announcing an accelerated $10-billion share buyback plan. L Brands rose 1.3% after reporting a surprise quarterly profit, boosted by strong demand for Bath & Body Works’ products as well as higher online sales of Victoria’s Secret lingerie.

Markets stumbled after the Fed’s minutes from its July meeting highlighted doubts about the U.S. economic recovery, showing that the swift labor market rebound seen in May and June had likely slowed. "Of course, the Fed agreed that the virus is weighing heavily on the economy: is that some kind of surprise? Apparently it was," Rabobank’s global strategist Michael Every wrote in a note to clients.

Yet despite the overall dovish sentiment, U.S. Treasury yields and the dollar surged with investors focusing on parts of the minutes that showed policymakers downplaying the need for yield caps and targets, nor did they hint at any additional QE.

"There is still a fair amount of uncertainty around the path of the coronavirus, through the flu season, and what that may mean for economic growth,” Jim McDonald, chief investment strategist at Northern Trust, said on Bloomberg TV. “Stocks are somewhat expensive here - we struggle to get to a meaningful positive return on stocks over the next year just because we’ve priced in so much of a recovery already."

As Bloomberg notes, equities in several continents are seeing fresh weakness as investors debate whether momentum that pushed the S&P 500 to a record high this week can be sustained amid lofty valuations and delays in further stimulus to counter the pandemic. While France, Spain and Austria reported the highest daily infections in months, cases have subsided in a few populous U.S. states. Weekly unemployment figures are due in Washington later Thursday.

"The key question for investors is whether the policy responses are enough to mitigate the economic damage,” hedge fund firm Brevan Howard said in an interim report published on Thursday.  "Many businesses face solvency risks that are not addressed by borrowing; a debt overhang cannot be cured by more borrowing no matter how cheap it may be,” the fund’s report added.

“Improved financial conditions are narrowly focused on a handful of large companies and benefiting stakeholders who need relatively little economic assistance. The result is that financial assets are expensive by many standard metrics. So long as a V-shaped recovery in risky assets fails to create a V-shaped recovery in economic activity, this tension is a recipe for increased volatility."

The MSCI world equity index was also impacted, sliding 0.6% early on Thursday. The pan-European STOXX 600 was down 0.9% and London’s FTSE 100 fell 0.8%. European equities slumped following a downbeat Asian session. Eurostoxx 50 dropped as much as 1.5%, with the CAC lagging peers. Miners, banking names and financial services are the worst performing sectors; real estate manages small gains

Earlier in the session, MSCI’s index of Asia-Pacific shares outside Japan had its biggest daily decline in five weeks. All markets in the region were down, with South Korea's Kospi Index dropping 3.7% and Taiwan's Taiex Index falling 3.3%. The Topix declined 0.9%, with Carta Holdings Inc and Mitani Sekisan falling the most. The Shanghai Composite Index retreated 1.3%, with Junzheng Energy and Yijiahe Tech posting the biggest slides. Hong Kong stocks fell for a second session as the U.S. suspended its extradition treaty with Hong Kong and ended reciprocal tax treatment with the former British colony.

In FX, the dollar index was choppy overnight after yesterday's sharp spike but appeared to resume rolling over following the news the US and China had agreed to resume trade talks.

Elsewhere, the euro fluctuated ahead of the release of the ECB meeting’s minutes, and the Norwegian Krone slipped after Norges Bank announced it will probably keep interest rates at a record low for "some time ahead." The Turkish lira tumbled after the central bank kept rates on hold. The CBRT also increased required FX reserves ratio for banks that meet growth target by 700bps for all maturities for precious metal repo accounts; all other RRR for FX raised by 200bps.

Treasuries reversed their Wednesady slump and were higher across the curve, led by the long end, amid gains for most developed sovereign bond markets and declines for equities globally. Yields are lower by about 4bp at long end, 10-year by ~3bp at 0.65%, flattening 2s10s and 5s30s curves by ~2bp; S&P 500 futures are lower after cash index Wednesday declined from a record high. 20-year yield is lower by 3bp at 1.165%. The new 20-year bond, which got a cool reception at Wednesday’s auction, is trading at a profit, as are the new 10-year and 30-year issues sold last week. This week’s final auction, a $7b 30-year TIPS reopening, is ahead at 1pm ET.

Germany’s benchmark 10-year Bund yield was at -0.473%, little changed after falling for the past four days in a row. Three-month Euribor fell to a record low, less than four months after rising to a four-year high, helped by the ECB’s policy to provide lenders with cheap loans in response to the economic damage of the pandemic.

In commodities, spot gold rebounded overnight, after declining to a near one-week low on Wednesday, when markets were more bullish. It was up 0.6% at $1,940.4478 per ounce. Oil prices fell, as major producers warned of a risk to demand recovery. OPEC and its allies pressed oil nations that are pumping above output targets to cut more in August to September. Brent crude was down 32 cents, or 0.7%, at $45.05 a barrel while WTI was down 38 cents, or 0.9%, at $42.55 a barrel.

Overnight, U.S. Congressional leaders hinted they were looking for a path toward reviving stalled talks on the next round of pandemic relief - even as both sides remain far from a deal. Any accord is still likely to wait until September despite the fact that the U.S. economy is limping along with many businesses still struggling and millions of Americans out of work.

On the day's calendar, data from the Labor Department, due at 8:30 a.m. ET (1230 GMT), is expected to show the number of Americans seeking jobless benefits dipped to 925,000 in the week ended Aug. 15.

Market Snapshot

  • S&P 500 futures down 0.4% to 3,360.00
  • Brent futures down 0.8% to $45.00/bbl
  • Gold spot up 0.3% to $1,934.33
  • U.S. Dollar Index up 0.3% to 93.16
  • Stoxx Europe 600 down 1.4% to 364.59
  • MXAP down 1.6% to 169.27
  • MXAPJ down 1.8% to 557.36
  • Nikkei down 1% to 22,880.62
  • Topix down 0.9% to 1,599.20
  • Hang Seng Index down 1.5% to 24,791.39
  • Shanghai Composite down 1.3% to 3,363.90
  • Sensex down 1.2% to 38,160.20
  • Australia S&P/ASX 200 down 0.8% to 6,120.02
  • Kospi down 3.7% to 2,274.22
  • German 10Y yield fell 1.2 bps to -0.484%
  • Euro down 0.2% to $1.1818
  • Italian 10Y yield fell 1.3 bps to 0.788%
  • Spanish 10Y yield rose 1.1 bps to 0.303%

Top Overnight News from Bloomberg

  • U.S. central bankers backed off in July from an earlier readiness to set a clearer bar for raising interest rates, a step that would underscore their commitment to an extended period of ultra-loose monetary policy
  • Coronavirus infections flared in Europe, with France and Spain reporting their biggest increases in months. South Korea confirmed 288 more cases, while Hong Kong’s outbreak showed signs of easing
  • French president Emmanuel Macron ruled out shutting down the country once again even as the virus resurges across several European nations. He said the “collateral damage of confinement is considerable”. Cases in France were up 3,776, the most in three months, while Spain recorded 3,715 new infections. Germany recorded more than 1,000 new infections for the third day in a row.
  • Russia’s opposition leader Alexey Navalny is in intensive care in “serious condition” with suspected poisoning. Navalny is Russia’s most prominent opponent to Vladimir Putin.
  • As Brexit trade talks approach their deadline, the European Union’s top markets regulator called for rule changes that could limit firms’ ability to manage money in the bloc from London.
  • China and the U.S. will hold talks in the near term to discuss the progress of their trade deal, Beijing said, without mentioning a precise date, after last week’s call was postponed.
  • Three-month Euribor fell to a record low, less than four months after rising to a four-year high, helped by the ECB’s policy to provide lenders with cheap loans in response to the economic damage of the pandemic.
  • The U.S. suspended its extradition treaty with Hong Kong and ended reciprocal tax treatment on shipping with the former British colony, the latest salvo in escalating tensions between Washington and Beijing
  • President Donald Trump said he would call on the United Nations Security Council to restore all nuclear- related sanctions on Iran, an attempt to kill off the 2015 nuclear agreement and force Tehran back to the negotiating table
  • OPEC+ kept up the pressure on Nigeria and Iraq to stop cheating on their crude-production targets, emphasizing the need for all members to stick closely to their agreement because the market recovery remains fragile
  • Kamala Harris, the California senator Joe Biden selected as his running mate, opened the third night of the Democrats’ virtual convention by urging the party to defy what she called a Republican effort to suppress their votes

Asian equity markets traded lower across the board amid headwinds from Wall St where stocks faltered in the aftermath of the less accommodative than expected FOMC Minutes which triggered a pullback in the S&P 500 and the Nasdaq from record highs, while Apple shares also retraced the majority of the early gains that had briefly pushed the tech giant to the unprecedented USD 2tln market cap status. ASX 200 (-0.8%) was pressured by a slate of weak earnings and with underperformance seen in energy names, while Nikkei 225 (-1.0%) retreated below the 23,000 level with Tokyo exporters dragged by a predominantly firmer currency. Hang Seng (-1.5%) and Shanghai Comp. (-1.3%) conformed to the downbeat tone after the US State Department either suspended or terminated three bilateral agreements with Hong Kong and reports also suggested the likelihood of a RRR cut this year has declined with the central bank expected to inject liquidity through reverse repos and MLF operations instead. In addition, the PBoC maintained the 1-year and 5-year Loan Prime Rates at 3.85% and 4.65% as expected, while there were reports US and Chinese trade negotiators plan to confer by video in the coming days regarding the Phase 1 trade deal progress and US actions against Chinese tech firms, although this failed to provide any support for stocks. Finally, 10yr JGBs were initially kept afloat by the risk averse tone but with the upside restricted following the post-FOMC pressure in T-notes and with participants sidelined heading into the 5yr JGB auction which turned out to a be a weaker than previous auction and subsequently weighed on prices.

Top Asian News

  • Saudi Support for 2002 Plan Shows It Won’t Copy UAE-Israel Pact
  • RBL Bank to Raise $209 Million With Preference Share Sale
  • Thailand Arrests Leaders of Protests Challenging the Monarchy
  • Philippines Central Bank Pauses After Series of Rate Cuts

European equities trade lower across the board (Eurostoxx 50 -1.3%) as market participants digest the fallout of the FOMC minutes which were judged to be less dovish than some had hoped for. Furthermore, geopolitical tensions have been ratcheted up once again in the wake of comments from US Secretary of State Pompeo who warned that the US will hold China and Russia accountable if they attempt to block sanctions snapback on Iran. Separate reports have noted that US and Chinese trade negotiators plan to confer by video in the coming days over Phase One progress, however, no date has been set yet and expectations for the call, should it take place, will likely be relatively low. In terms of the tone of the market in Europe, all sectors trade in the red, with some of the more defensive sectors such as health care and utilities faring slightly better than peers, but ultimately still lower on the day. Basic resources are a laggard in the region following recent declines in both precious and base metals and post-Antofagasta (-4.8%) earnings with the Co. reporting a 22.4% decline in H1 core earnings amid the COVID-19 crisis; note, the Co. will nonetheless pay an interim dividend. Somewhat of a divergence has been seen in the travel & leisure sector with airlines such as IAG (-4.8%), Ryanair (-3.1%) and easyJet (-2.3%) lower as the UK is set to further expand its list of countries which will force travelers to self-isolate upon return. Conversely, hotel names are faring slightly better with Accor (+0.7%) and InterContinental Hotels (+1.0%) supported by reports in French media suggesting that the former could put in a bid for the latter. Elsewhere, as part of a more anti-cyclical bias, banks and auto names are faring relatively poorly this morning, for banks-specifically, some of the laggards are predominantly Spanish names, which could be a reflection of mounting COVID-19 cases in the nation.

Top European News

  • Schaeffler Looks to Raise $1.5 Billion Amid Pandemic Fallout
  • Swedish Match Misrepresented Oral Nicotine, Lawmakers Say
  • Macron Rules Out Shutdown as Europe Grapples With Virus Upsurge
  • Adyen Clinches Wirecard Clients During Online Shopping Boom

In FX, the DXY index oscillates on either side of 93.000 in the aftermath of the FOMC minutes - which pushed back on expectations that further policy action will arrive soon as it indicated that members are not inclined to a forward guidance change and YCC. The release propped up the broader Dollar and index back above the 93.000 mark to a high (yesterday) at 93.059, but thereafter trickled back below the figure as the dust settled in early European hours. The index has since regained traction and printed a fresh intraday peak just under 93.200. with the 21 DMA in proximity at 93.336. US stimulus talks will likely regain focus alongside US-Sino developments, whilst US Philly Fed and the weekly initial and continuing jobless claims, and Fed non-voter Daly are on today’s docket.

  • AUD, NZD, CAD, GBP, EUR - All softer against the Buck to various degrees, with the non-US Dollars taking their cue from the subdued risk tone across the market, with the antipodeans bearing the brunt of the pressure. AUD/USD remains sub-0.7200 having had dipped below its 21 DMA (0.7165) in early European trade, whilst the NZD/USD meanders around its 50 DMA (0.6550) after side-lining comments from RBNZ Assistant Governor Hawkesby whose speech largely proved to be a rehash of recent communication. The Loonie also see modest weakness, albeit fares better than its antipodean counterparts, with USD/CAD matching Tuesday’s high around 1.3231 but remaining contained within a tight band ahead of BoC Deputy Governor Beaudry’s panel discussion later today.  The core European FX trade in tandem with the Dollar. EUR/USD is edging closer towards 1.1800 to the downside from 1.1868 at best ahead of its 21 DMA at 1.1789 as trades eye the release of the ECB Minutes (Full preview available in the Research Suite). EUR/GBP resides around its 50 DMA (0.9034) having had printed a current parameter of 0.9030-69. Note: EUR/USD sees several large option expiries for today’s NY cut, including EUR 833mln at 1.1800, EUR 2.2bln between 1.1840-50 and 1.4bln at 1.1900.
  • NOK, SEK - The Norwegian Crown saw little immediate reaction upon the release of the Norges Bank decision, which kept rates unchanged and reiterated forward guidance as expected with focus turning to the September update for a possible tweak to the repo path. The NOK however is weaker on the day but more so a function of the risk tone across the market, with EUR/NOK closer to the top of its current parameter 10.5380-5940, albeit faring better than its Swedish counterpart which sees more pronounced losses despite the Swedish unemployment rate printing below forecasts. EUR/SEK continues gaining above 10.3000 with a current high of 10.3380.
  • CHF, JPY - Both modestly firmer against the USD as the risk averse tone persists during early EU hours, with EUR/CHF straddling around the 1.0800 (vs. 1.0842 at best) mark whilst USD/JPY encounters a barrier at 106.00 to the downside from a high of 106.21.
  • EM - EM FX conforms to the overall risk tone with broad-based losses seen across most pairs. USD/TRY gears up for the CBRT’s rate decision where no change is expected to the One-Week Repo rate amid a number of “backdoor” policy tightening measures taken up by the bank to stem the Lira’s freefall, although some have flagged the possibly of hikes to its overnight lending rate alongside its late liquidity window, currently at 9.75% and 11.25% respectively. Meanwhile, the CNH remains resilient to broader USD action after the PBoC left its LPR setting unchanged, whilst Chinese press noted that  the likelihood of the PBoC lowering RRR this year has declined, with the central bank expected to inject liquidity through reverse repos and MLF.
  • RBNZ Assistant Governor Hawkesby said the balance sheet will continue to expand as it supports the economy while the size and composition of the balance sheet will become a more active instrument for monetary policy decisions. Furthermore, Hawkesby added that it is not necessarily the case that the central bank's balance sheets should revert to their former levels  and reiterated the view that a lower or negative OCR, funding for lending programme, foreign asset purchases and interest rate swaps remain possible options. (Newswires)

In commodities, WTI and Brent October futures hold onto modest losses in the aftermath of the FOMC-induced USD strength and the fallout of the JMMC meeting – which in a nutshell reaffirmed the commitments to the OPEC+ deal, made no recommendations for changes to the output target and emphasised the importance of compliance; laggards set to submit their over-compliance plans to the JMMC by August 28th. Note, Argus media citing delegates stated that OPEC+ needs a cumulative 2.3bln BPD of cuts over the next two months to make up for the stragglers’ shortfalls, albeit journalists with access to the ministers’ memo of the meeting say there is no such mention. WTI October meanders around USD 42.75/bbl (vs. high 42.98/bbl) while its Brent counterpart trades on either side of USD 45/bbl (vs. high 45.18/bbl). Elsewhere, spot gold and silver remain impaired by post-FOMC losses sub-USD 1950/oz and below USD 28/oz respectively as a firmer Dollar persists, having had traded within a USD 25/oz intraday range thus far. In terms of base metals, LME copper prices remain subdued by the Dollar and as the red metals track the equity sell-off, whilst Dalian iron ore futures ended the overnight session lower by over 1% against the same backdrop.

US Event Calendar

  • 8:30am: Philadelphia Fed Business Outlook, est. 20.8, prior 24.1
  • 8:30am: Initial Jobless Claims, est. 920,000, prior 963,000; Continuing Claims, est. 15m, prior 15.5m
  • 9:45am: Bloomberg Economic Expectations, prior 38.5; Bloomberg Consumer Comfort, prior 43.7
  • 10am: Leading Index, est. 1.1%, prior 2.0%

DB's Craid Nicol concludes the overnight wrap

The repetitiveness of virus, fiscal and geopolitical headlines was finally put to one side yesterday with last night’s FOMC minutes offering an insight into the latest thinking over at the Fed. The minutes showed a Fed that aimed to wrap up its review in the ‘near future’ - most likely at the September meeting - though did not see a massive urgency to provide additional monetary accommodation. Neither were there any clues about imminent changes in either the size of composition of QE. The minutes also showed that officials were unenthusiastic about yield curve control, with our economists continuing to expect the Fed to move towards average inflation targeting. See our US economists’ full recap on the minutes here.

The minutes had enough in them to see equities make a decent U-turn. By the close of play the S&P 500 finished -0.44%, falling -0.71% in the last two hours of the session after the release. The NASDAQ also lost -0.57%, however not before Apple’s market cap had briefly passed the $2tn mark for the first time ever – the first US company to do so. Keep in mind that Apple’s market cap dipped below $1tn on March 23rd. So that works out to over $6.7bn of value added for every business day since, which is staggering. For context it took four decades for Apple to reach a $1tn market cap in 2018.

The dollar has been moving in a hurry in recent weeks too however yesterday did see a large reversal of some of the recent weakness with the dollar index bouncing back +0.67%. Half the move came after the minutes were released and it’s held onto gains overnight too. As for rates, 10y yields ended the session +1.1bps having traded a touch lower going into in the minutes although they have reversed much of that move overnight. The same goes for the bear steepening which was a big talking point last week, with 2s10s up +1.3bps and 5s30s up +2.4bps yesterday but curves flatter this morning.

This morning in Asia markets are following Wall Street’s lead with the Nikkei (-0.88%), Hang Seng (-2.11%), Shanghai Comp (-1.08%), Kospi (-2.93%) and ASX (-0.91%) all in the red. The move for the Kospi hasn’t been helped by the latest virus data in South Korea, with a reported 288 cases in the past 24 hours. Meanwhile, reports that the US has suspended its extradition treaty with Hong Kong and ended reciprocal tax treatment on shipping also isn’t helping broad sentiment this morning, as is the news that President Trump is calling on the UN to renew all nuclear-related sanctions on Iran. Futures on the S&P 500 are also down -0.64% while spot gold and silver prices are up +1.15% and +1.88% respectively.

Back to yesterday, where some of the focus was on earnings in the US retail sector – notably from Target, Lowe’s and TJX. The former’s shares were the best performing in the S&P, jumping +12.65% after reporting both record profit and sales last quarter. Lowe’s share price was up a much more modest +0.30%. Even though the home improvement store beat sales growth expectations, the stock was dragged lower with the overall index over the course of the day. TJX was down -5.33% after announcing that they expect sales this quarter will fall over -20%, as the business model is more geared to in-store purchases rather than online.

In other news, White House Chief of Staff Mark Meadows said yesterday on fiscal discussions that “the outlook for a skinny deal is better than it’s ever been, and we’re still not there”. That followed the comments from Pelosi who suggested there could be a meet in the middle near term solution and a Bloomberg story which suggested that the Trump administration sees a possibility for the two sides to agree on a pared-down $500bn deal that would omit the biggest areas of disappointment for now. The question remains whether the market would see this as enough and whether it would be enough to filter through the economy and into late summer/early fall economic data.

Meanwhile, in emerging markets the Turkish lira rallied after reports yesterday that the country had made an energy discovery in the Black Sea, which was most likely natural gas. We don’t have the full details yet, but the market reaction was notable, with the currency strengthening by +1.17% against the US dollar. Other Turkish assets similarly rallied, with the country’s BIST 100 equity index up +2.95%. Turkey is likely to be in the headlines again today with a monetary policy decision expected later. Our economists are anticipating a hike in the 1w repo rate to an above-consensus 10.0%.

As for the rest of markets yesterday, in Europe the STOXX 600 closed up +0.65% while European banks rallied +2.04%. That was despite bond markets in Europe closing down 1-2bps. In commodities Gold ended -3.67% lower as the dollar rallied, while WTI oil was -0.23%. Finally, in credit markets both HY and IG spreads were little changed in both the US and Europe. On that note, this week we published a report titled “Is duration risk the new credit risk in IG”, specifically looking at the impact of a pick-up in long dated issuance in the US IG market and the subsequent shift that has had in terms of spread duration. See the full note here.

Wrapping things up, in terms of data yesterday, there was a big upward surprise in the UK’s CPI reading, which came in at +1.0% in July (vs. +0.6% expected), whilst core CPI also surprised to the upside at +1.8%. It was the reverse picture in Canada however, where July’s CPI fell to +0.1% (vs. +0.5% expected). Finally, we also had the World Trade Organization’s Goods Trade Barometer, which fell to its lowest since data began back in 2007 at 84.5, below the baseline value of 100 and -18.6 points lower than at the same point a year ago.

To the day ahead now, and there are a number of data highlights from the US, including the weekly initial jobless claims, the leading index for July, as well as August’s Philadelphia Fed business outlook. Over in Europe, we’ll get the latest ECB minutes from their July meeting, as well as the German PPI reading for July. On the central bank front, there’s also a monetary policy decision from the Central Bank of Turkey, as well as remarks from San Francisco Fed President Daly. Finally, the Democratic convention will wrap up tonight, with their presidential candidate Joe Biden due to speak.

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Spread & Containment

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

Trending